26 January 2021

Par Portfolio Company, Manus Neurodynamica recently closed a £1.2m funding round to support the launch of its digital pen, which detects early indicators of Parkinson’s disease. 

To date, the company has secured £5 million in funding, including a £750,000 financing round in May last year, led by Par Equity. Investors in this round include the North East Innovation Fund, SIS Ventures and Old College Capital. 

Read the full article here: http://bit.ly/2M3Wjva